Discovery of ITX 4520: A highly potent orally bioavailable hepatitis C virus entry inhibitor

被引：19

作者：

Mittapalli, Gopi Kumar ^{[1
]}

Zhao, Fang ^{[1
]}

Jackson, Andrew ^{[1
]}

Gao, Hongfeng ^{[1
]}

Lee, Haekyung ^{[1
]}

Chow, Stephine ^{[1
]}

Kaur, Maninder Pal ^{[1
]}

Natalie Nguyen ^{[1
]}

Zamboni, Robert ^{[1
]}

McKelvy, Jeffrey ^{[1
]}

Wong-Staal, Flossie ^{[1
]}

Macdonald, James E. ^{[1
]}

机构：

[1] iTherX Pharmaceut Inc, San Diego, CA 92191 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2012年 / 22卷 / 15期

关键词：

Hepatitis C virus; Entry inhibitors; Bioisostere; Oral bioavailability; Scavenger receptor B-1; HCV ENTRY; INFECTION; RECEPTOR; CULTURE; DRUGS;

D O I：

10.1016/j.bmcl.2012.06.038

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The manuscript reports an identification of a highly potent, orally bioavailable hepatitis C virus entry inhibitor through optimization of a previously reported class of molecules (1) that were not stable in the rat plasma. Compound 39 (ITX 4520) exhibited an excellent PK profile in both rats and dogs with good oral exposure, half-life and oral bioavailability. The compound is also well-tolerated in the preliminary in vivo toxicity studies and has been selected as a pre-clinical candidate for our HCV clinical pipeline. (c) 2012 Elsevier Ltd. All rights reserved.

引用

页码：4955 / 4961

页数：7

共 50 条

[1] Discovery of highly potent small molecule Hepatitis C Virus entry inhibitors
Mittapalli, Gopi Kumar
Jackson, Andrew
Zhao, Fang
Lee, Haekyung
Chow, Stephine
McKelvy, Jeffrey
Wong-Staal, Flossie
Macdonald, James E.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (22) : 6852 - 6855
[2] Discovery of a Pyrimidinedione Derivative as a Potent and Orally Bioavailable Axl Inhibitor
Zhang, Hefeng
Peng, Xia
Dai, Yang
Shao, Jingwei
Ji, Yinchun
Sun, Yiming
Liu, Bo
Cheng, Xu
Ai, Jing
Duan, Wenhu
JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (07) : 3956 - 3975
[3] A novel, potent, and orally bioavailable thiazole HCV NS5A inhibitor for the treatment of hepatitis C virus
Yeh, Teng-Kuang
Kang, Iou-Jiun
Hsu, Tsu-An
Lee, Yen-Chun
Lee, Chung-Chi
Hsu, Sheng-Ju
Tian, Ya-Wen
Yang, Hui-Yun
Chen, Chiung-Tong
Chao, Yu-Sheng
Yueh, Andrew
Chern, Jyh-Haur
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 167 : 245 - 268
[4] Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor
Johnson, Douglas S.
Stiff, Cory
Lazerwith, Scott E.
Kesten, Suzanne R.
Fay, Lorraine K.
Morris, Mark
Beidler, David
Liimatta, Marya B.
Smith, Sarah E.
Dudley, David T.
Sadagopan, Nalini
Bhattachar, Shobha N.
Kesten, Stephen J.
Nomanbhoy, Tyzoon K.
Cravatt, Benjamin F.
Ahn, Kay
ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (02): : 91 - 96
[5] Discovery of HCV-796: A potent and orally bioavailable hepatitis-C polymerase inhibitor under clinical development
Saha, Ashis K.
Young, C.
Del Vecchio, A. M.
Bailey, T. A.
Reinhardt, J. A.
Kulkarni, B. A.
Faitg, T. H.
Feng, H.
Rippin, S. R.
Blackledge, C. W.
Rys, D. J.
Lessen, T. A.
Swestock, J.
Deng, Y.
Nitz, T. J.
Chunduru, S.
Chopra, R.
Collett, M.
Pevear, D.
Howe, A. Y. M.
O'Connell, J.
Mansour, T.
Burns, C. J.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 577 - 577
[6] Discovery of Ziresovir as a Potent, Selective, and Orally Bioavailable Respiratory Syncytial Virus Fusion Protein Inhibitor
Zheng, Xiufang
Gao, Lu
Wang, Lisha
Liang, Chungen
Wang, Baoxia
Liu, Yongfu
Feng, Song
Zhang, Bo
Zhou, Mingwei
Yu, Xin
Xiang, Kunlun
Chen, Li
Guo, Tao
Shen, Hong C.
Zou, Gang
Wu, Jim Zhen
Yun, Hongying
JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (13) : 6003 - 6014
[7] Discovery of PF-04449913, a Potent and Orally Bioavailable Inhibitor of Smoothened
Munchhof, Michael J.
Li, Qifang
Shavnya, Andrei
Borzillo, Gary V.
Boyden, Tracey L.
Jones, Christopher S.
LaGreca, Susan D.
Martinez-Alsina, Luis
Patel, Nandini
Pelletier, Kathleen
Reiter, Larry A.
Robbins, Michael D.
Tkalcevic, George T.
ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (02): : 106 - 111
[8] Discovery of a highly potent orally bioavailable imidazo-[1, 2-a]pyrazine Aurora inhibitor
Yu, Tao
Zhang, Yonglian
Kerekes, Angela D.
Tagat, Jayaram R.
Doll, Ronald J.
Xiao, Yushi
Esposite, Sara
Hruza, Alan
Belanger, David B.
Voss, Matthew
Rainka, Matthew P.
Basso, Andrea
Liu, Ming
Liang, Lianzhu
Sui, Ning
Prelusky, Daniel
Rindgen, Diane
Zhang, Likang
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (08) : 1397 - 1403
[9] DISCOVERY OF POTENT AND SELECTIVE INHIBITORS OF HEPATITIS C VIRUS (HCV) ENTRY
Coburn, Glen
Han, Amy Q.
de Muys, Jean-Marc
Gauss, Carla
Provoncha, Kathleen
Canfield, Melissa
Paul, Dorothy
Mohamed, Seema
Moorji, Sameer
Fisch, Danielle
Murga, Jose D.
Rotshteyn, Yakov
Qian, Dapeng
Maddon, Paul J.
Olson, William C.
HEPATOLOGY, 2008, 48 (04) : 1162A - 1162A
[10] Allosteric inhibitors of hepatitis C polymerase: Discovery of potent and orally bioavailable carbon-linked dihydropyrones
Li, Hui
Linton, Angelica
Tatlock, John
Gonzalez, Javier
Borchardt, Allen
Abreo, Mel
Jewell, Tanya
Patel, Leena
Drowns, Matthew
Ludlum, Sarah
Goble, Mike
Yang, Michele
Blazel, Julie
Rahavendran, Ravi
Skor, Heather
Shi, Stephanie
Lewis, Cristina
Fuhrman, Shella
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (17) : 3969 - 3972

← 1 2 3 4 5 →